J. Herrmann

1.0k total citations
61 papers, 712 citations indexed

About

J. Herrmann is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, J. Herrmann has authored 61 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in J. Herrmann's work include Thyroid Disorders and Treatments (29 papers), Pituitary Gland Disorders and Treatments (4 papers) and Ion channel regulation and function (4 papers). J. Herrmann is often cited by papers focused on Thyroid Disorders and Treatments (29 papers), Pituitary Gland Disorders and Treatments (4 papers) and Ion channel regulation and function (4 papers). J. Herrmann collaborates with scholars based in Germany, Hungary and United States. J. Herrmann's co-authors include H. L. Krüskemper, Ursula Schneider, Diana M. Morales‐Prieto, Wittaya Chaiwangyen, Bernd Gruhn, Stephanie Ospina‐Prieto, Udo R. Markert, H. L. Krüskemper, Peter A. Hilger and Oumar Camara and has published in prestigious journals such as Journal of Clinical Oncology, Endocrinology and The American Journal of Cardiology.

In The Last Decade

J. Herrmann

56 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Herrmann Germany 13 256 166 163 138 134 61 712
M. T. Chau China 11 243 0.9× 188 1.1× 89 0.5× 168 1.2× 26 0.2× 20 652
Jacques Mailloux Canada 16 345 1.3× 185 1.1× 143 0.9× 82 0.6× 45 0.3× 19 1.2k
Anna Wickman Sweden 16 277 1.1× 231 1.4× 56 0.3× 87 0.6× 41 0.3× 27 736
Ossama M. Reslan United States 13 145 0.6× 113 0.7× 177 1.1× 128 0.9× 45 0.3× 24 646
Louise Greenberg United States 7 803 3.1× 62 0.4× 49 0.3× 144 1.0× 78 0.6× 10 1.2k
Satoru Akazawa Japan 16 284 1.1× 251 1.5× 176 1.1× 322 2.3× 20 0.1× 46 965
M. Elizabeth Moss United States 14 300 1.2× 121 0.7× 112 0.7× 242 1.8× 22 0.2× 15 611
E. Bolté Canada 14 703 2.7× 124 0.7× 99 0.6× 615 4.5× 143 1.1× 23 1.1k
Liliya M. Yamaleyeva United States 18 247 1.0× 155 0.9× 201 1.2× 139 1.0× 13 0.1× 38 833
Sumra Nazir Germany 9 63 0.2× 330 2.0× 117 0.7× 93 0.7× 61 0.5× 12 715

Countries citing papers authored by J. Herrmann

Since Specialization
Citations

This map shows the geographic impact of J. Herrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Herrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Herrmann more than expected).

Fields of papers citing papers by J. Herrmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Herrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Herrmann. The network helps show where J. Herrmann may publish in the future.

Co-authorship network of co-authors of J. Herrmann

This figure shows the co-authorship network connecting the top 25 collaborators of J. Herrmann. A scholar is included among the top collaborators of J. Herrmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Herrmann. J. Herrmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morales‐Prieto, Diana M., Wittaya Chaiwangyen, Stephanie Ospina‐Prieto, et al.. (2012). MicroRNA expression profiles of trophoblastic cells. Placenta. 33(9). 725–734. 216 indexed citations
2.
Szabolcs, I., et al.. (2009). Reference Intervals for Serum Thyrotropin: Dependence on the Population Investigated. Experimental and Clinical Endocrinology & Diabetes. 98(4). 23–31. 1 indexed citations
3.
Camara, Oumar, et al.. (2009). Venous coupler for free-flap anastomosis.. PubMed. 29(7). 2827–30. 29 indexed citations
4.
Herrmann, J.. (2008). Prophylaxe und Therapie der jodinduzierten Hyperthyreose. DMW - Deutsche Medizinische Wochenschrift. 116(3). 99–101.
6.
Herrmann, J., et al.. (2002). Prognostic implication of cardiac troponin T increase following stent implantation. Heart. 87(6). 549–553. 52 indexed citations
7.
Eggebrecht, Holger, Christian Bruch, Michael Haude, et al.. (2000). Transluminale Ausschaltung eines Arteria subclavia-Aneurysmas mittels Stent-Graft-Implantation. Zeitschrift für Kardiologie. 89(9). 761–765. 4 indexed citations
8.
Birgelen, Clemens von, Michael Haude, J. Herrmann, et al.. (1999). Early clinical experience with the implantation of a novel synthetic coronary stent graft. Catheterization and Cardiovascular Interventions. 47(4). 496–503. 23 indexed citations
9.
Szabolcs, I., et al.. (1990). Screening of Geriatric Patients for Thyroid Dysfunction with Thyrotropin-Releasing-Hormone Test, Sensitive Thyrotropin and Free Thyroxine Estimation. Hormone and Metabolic Research. 22(5). 298–302. 19 indexed citations
10.
Joka, T, U. Obertacke, J. Herrmann, et al.. (1988). Beeinflusst die bronchoalveoläre Lavage das Milieu in der Alveole. 1 indexed citations
11.
Herrmann, J., et al.. (1985). Thyroid Hormone Binding Inhibitor (THBI) Mainly Associated with Serum Oleic Acid Concentration. Hormone and Metabolic Research. 17(8). 426–427. 15 indexed citations
12.
Herrmann, J., et al.. (1978). [Thyroid-function parameters in liver diseases].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 29(48). 1888–92. 4 indexed citations
13.
Herrmann, J.. (1978). Neuere Aspekte in der Therapie der thyreotoxischen Krise. DMW - Deutsche Medizinische Wochenschrift. 103(4). 166–174. 5 indexed citations
14.
Herrmann, J., D. Schaps, Mitchell B. Berger, et al.. (1975). SERUM TRIIODOTHYRONINE 7–15 YEARS AFTER FRACTIONATED LOW DOSE RADIOIODINE THERAPY OF THYROTOXICOSIS. Clinical Endocrinology. 4(2). 205–212. 2 indexed citations
15.
Herrmann, J., et al.. (1975). Exzessive periphere Konversion von Thyroxin (T4) zu Trijodthyronin (T3) in der Pathogenese der T3-Hyperthyreose. DMW - Deutsche Medizinische Wochenschrift. 100(45). 2319–2323. 3 indexed citations
16.
Herrmann, J., et al.. (1974). Rapid radioimmunoassay for the evaluation of thyroxine in unextracted serum. Clinica Chimica Acta. 54(1). 69–79. 14 indexed citations
17.
Hilger, Peter A., J. Herrmann, & H. L. Krüskemper. (1973). Radioimmunologische Schnellmethode zur Messung von Trijodthyronin im Serum ohne Extraktion. Clinical Chemistry and Laboratory Medicine (CCLM). 11(8).
18.
Herrmann, J., et al.. (1972). [Genetically induced changes in the concentration of thyroxin-binding globulin and their significance for the differential diagnosis of thyroid function disorders].. PubMed. 13(2). 37–40.
19.
Krüskemper, Gertrud, et al.. (1970). OBSERVATIONS UNDER TREATMENT WITH NORETHISTERONE-ENANTHATE. European Journal of Endocrinology. 65(4_Suppla). S64–S64. 1 indexed citations
20.
Herrmann, J. & H. L. Krüskemper. (1968). Bestimmung des freien Thyroxins im Serum mit125J-markiertem Thyroxin. Journal of Molecular Medicine. 46(23). 1285–1286. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026